-
Je něco špatně v tomto záznamu ?
VariClose® vein sealing system is inferior to endovenous laser ablation for the treatment of varicose veins
P. Balaz, S. Rokosny, A. Whitley
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články
- MeSH
- laserová terapie * škodlivé účinky metody MeSH
- lidé MeSH
- retrospektivní studie MeSH
- varixy * diagnostické zobrazování chirurgie MeSH
- vena saphena diagnostické zobrazování chirurgie MeSH
- výsledek terapie MeSH
- žilní insuficience * diagnostické zobrazování chirurgie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
BACKGROUND: One of the three commercially available cyanoacrylate venous glues used for the treatment of saphenous vein insufficiency is the VariClose® vein sealing system. Previous studies have documented a high rate of occlusion and minimal postoperative complications. The aim of this study was to compare occlusion rates and clinical outcomes of endovenous laser treatment with the VariClose® vein sealing system in the treatment of truncal vein insufficiency. PATIENTS AND METHODS: Retrospective non-randomized single center study with prospectively collected data comparing endovenous laser treatment and VariClose® procedures between April 2018 and November 2019. RESULTS: VariClose® was used in 27 patients (30 veins) and endovenous laser treatment in 42 patients (51 veins). The occlusion rate at one, three, and six months were 96%, 85%, and 65% for VariClose® procedures and 100%, 100%, and 97% for endovenous laser treatment procedures (p = 0.01), respectively. Reduction of VCSS scores before treatment and at the last postoperative follow-up visit in the VariClose® group dropped by an average of 1.8 ± 1.6 and in the endovenous laser treatment by an average of 3.3 ± 2.9 (p = 0.01). CONCLUSION: VariClose® vein sealing system is inferior to endovenous laser treatment as a treatment option for varicose veins as it has a higher recanalization rate.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22018276
- 003
- CZ-PrNML
- 005
- 20220804134653.0
- 007
- ta
- 008
- 220720s2022 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1177/17085381211013975 $2 doi
- 035 __
- $a (PubMed)34024200
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Balaz, Peter $u Department of Surgery, Faculty Hospital Kralovske Vinohrady, Third Faculty of Medicine, Charles University, Prague, Czech Republic $u Department of Vascular Surgery, National Institute for Cardiovascular Disease, Bratislava, Slovak Republic
- 245 10
- $a VariClose® vein sealing system is inferior to endovenous laser ablation for the treatment of varicose veins / $c P. Balaz, S. Rokosny, A. Whitley
- 520 9_
- $a BACKGROUND: One of the three commercially available cyanoacrylate venous glues used for the treatment of saphenous vein insufficiency is the VariClose® vein sealing system. Previous studies have documented a high rate of occlusion and minimal postoperative complications. The aim of this study was to compare occlusion rates and clinical outcomes of endovenous laser treatment with the VariClose® vein sealing system in the treatment of truncal vein insufficiency. PATIENTS AND METHODS: Retrospective non-randomized single center study with prospectively collected data comparing endovenous laser treatment and VariClose® procedures between April 2018 and November 2019. RESULTS: VariClose® was used in 27 patients (30 veins) and endovenous laser treatment in 42 patients (51 veins). The occlusion rate at one, three, and six months were 96%, 85%, and 65% for VariClose® procedures and 100%, 100%, and 97% for endovenous laser treatment procedures (p = 0.01), respectively. Reduction of VCSS scores before treatment and at the last postoperative follow-up visit in the VariClose® group dropped by an average of 1.8 ± 1.6 and in the endovenous laser treatment by an average of 3.3 ± 2.9 (p = 0.01). CONCLUSION: VariClose® vein sealing system is inferior to endovenous laser treatment as a treatment option for varicose veins as it has a higher recanalization rate.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a laserová terapie $x škodlivé účinky $x metody $7 D053685
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a vena saphena $x diagnostické zobrazování $x chirurgie $7 D012501
- 650 _2
- $a výsledek terapie $7 D016896
- 650 12
- $a varixy $x diagnostické zobrazování $x chirurgie $7 D014648
- 650 12
- $a žilní insuficience $x diagnostické zobrazování $x chirurgie $7 D014689
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Rokosny, Slavomir $u Department of Surgery, Faculty Hospital Kralovske Vinohrady, Third Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Whitley, Adam $u Department of Surgery, Faculty Hospital Kralovske Vinohrady, Third Faculty of Medicine, Charles University, Prague, Czech Republic $u Department of Anatomy, Second Faculty of Medicine, Charles University, Prague, Czech Republic $1 https://orcid.org/000000024415172X
- 773 0_
- $w MED00007624 $t Vascular $x 1708-539X $g Roč. 30, č. 3 (2022), s. 542-547
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34024200 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220720 $b ABA008
- 991 __
- $a 20220804134647 $b ABA008
- 999 __
- $a ok $b bmc $g 1822058 $s 1169519
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 30 $c 3 $d 542-547 $e 20210522 $i 1708-539X $m Vascular $n Vasc $x MED00007624
- LZP __
- $a Pubmed-20220720
